-
EP3524679
European procedure
Extract from the Register of European Patents
EP About this file: EP3524679
| EP3524679 - MICRO-RNA MIR-19 AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT OF MEDICAL CONDITIONS IN WHICH LOW ADRENALINE OR NORADRENALINE LEVEL IS THERAPEUTICALLY BENEFICIAL [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.08.2022 Database last updated on 11.05.2024 | |
| Former | The patent has been granted Status updated on 03.09.2021 | ||
| Former | Grant of patent is intended Status updated on 19.05.2021 | ||
| Former | Examination is in progress Status updated on 20.05.2020 | ||
| Former | Request for examination was made Status updated on 12.07.2019 | Most recent event Tooltip | 03.05.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 05.06.2024 [2024/23] | Applicant(s) | For all designated states Yeda Research and Development Co., Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | [2019/33] | Inventor(s) | 01 /
Chen, Alon 3 Ashbal Street the Weizmann Institute of Science 7610002 Rehovot / IL | 02 /
Hornstein, Eran 54 HaNassi HaRishon Street 7630243 Rehovot / IL | 03 /
Issler, Orna c/o Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | 04 /
Haramati, Sharon c/o Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | 05 /
Volk, Naama c/o Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science P.O. Box 95 7610002 Rehovot / IL | [2021/40] |
| Former [2019/33] | 01 /
Chen, Alon 3 Ashbal Street the Weizmann Institute of Science 7610002 Rehovot / IL | ||
| 02 /
Hornstein, Eran 54 HaNassi HaRishon Street 7630243 Rehovot / IL | |||
| 03 /
Issler, Orna P.O. Box 95 c/o Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science 7610002 Rehovot / IL | |||
| 04 /
Haramati, Sharon P.O. Box 95 c/o Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science 7610002 Rehovot / IL | |||
| 05 /
Volk, Naama P.O. Box 95 c/o Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science 7610002 Rehovot / IL | Representative(s) | Gulde & Partner Patent- und Rechtsanwaltskanzlei mbB Wallstraße 58/59 10179 Berlin / DE | [2019/33] | Application number, filing date | 19164042.4 | 02.08.2012 | [2019/33] | Priority number, date | US201161514954P | 04.08.2011 Original published format: US 201161514954 P | [2019/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3524679 | Date: | 14.08.2019 | Language: | EN | [2019/33] | Type: | B1 Patent specification | No.: | EP3524679 | Date: | 06.10.2021 | Language: | EN | [2021/40] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 12.07.2019 | Classification | IPC: | C12N15/113, A61K31/713 | [2019/33] | CPC: |
A61K31/7105 (EP,CN,US);
A61K31/713 (EP,CN,US);
A61K48/0058 (US);
A61P15/00 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P3/00 (EP);
A61P3/02 (EP);
A61P35/00 (EP);
A61P39/00 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
C12N15/113 (EP,CN,US);
C12Q1/6883 (EP,US);
| C-Set: |
A61K31/7105, A61K2300/00 (CN);
A61K31/713, A61K2300/00 (CN) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/33] | Title | German: | MIKRO-RNA MIR-19 UND ZUSAMMENSETZUNGEN DAMIT ZUR BEHANDLUNG MEDIZINISCHER ZUSTÄNDE, BEI DENEN EIN NIEDRIGER ADRENALIN- ODER NORADRENALINSPIEGEL THERAPEUTISCH SINNVOLL IST | [2019/33] | English: | MICRO-RNA MIR-19 AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT OF MEDICAL CONDITIONS IN WHICH LOW ADRENALINE OR NORADRENALINE LEVEL IS THERAPEUTICALLY BENEFICIAL | [2019/33] | French: | MICRO ARN MIR-19 ET COMPOSITIONS LES COMPRENANT POUR LE TRAITEMENT D'ÉTATS MÉDICAUX DANS LESQUELS LE NIVEAU D'ADRÉNALINE FAIBLE OU DE NORADRÉNALINE EST BÉNÉFIQUE THÉRAPEUTIQUEMENT | [2019/33] | Examination procedure | 20.03.2019 | Examination requested [2019/33] | 04.02.2020 | Amendment by applicant (claims and/or description) | 27.05.2020 | Despatch of a communication from the examining division (Time limit: M02) | 24.07.2020 | Reply to a communication from the examining division | 08.10.2020 | Despatch of a communication from the examining division (Time limit: M02) | 30.11.2020 | Reply to a communication from the examining division | 20.05.2021 | Communication of intention to grant the patent | 30.08.2021 | Fee for grant paid | 30.08.2021 | Fee for publishing/printing paid | 30.08.2021 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP12759827.4 / EP2739736 | EP17163200.3 / EP3208338 | Opposition(s) | 07.07.2022 | No opposition filed within time limit [2022/37] | Fees paid | Renewal fee | 20.03.2019 | Renewal fee patent year 03 | 20.03.2019 | Renewal fee patent year 04 | 20.03.2019 | Renewal fee patent year 05 | 20.03.2019 | Renewal fee patent year 06 | 20.03.2019 | Renewal fee patent year 07 | 26.08.2019 | Renewal fee patent year 08 | 20.08.2020 | Renewal fee patent year 09 | 30.08.2021 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 02.08.2012 | AL | 06.10.2021 | AT | 06.10.2021 | CY | 06.10.2021 | CZ | 06.10.2021 | DK | 06.10.2021 | EE | 06.10.2021 | ES | 06.10.2021 | FI | 06.10.2021 | HR | 06.10.2021 | IT | 06.10.2021 | LT | 06.10.2021 | LV | 06.10.2021 | MC | 06.10.2021 | MK | 06.10.2021 | NL | 06.10.2021 | PL | 06.10.2021 | RO | 06.10.2021 | RS | 06.10.2021 | SE | 06.10.2021 | SI | 06.10.2021 | SK | 06.10.2021 | SM | 06.10.2021 | BG | 06.01.2022 | NO | 06.01.2022 | GR | 07.01.2022 | IS | 06.02.2022 | PT | 07.02.2022 | [2024/23] |
| Former [2024/20] | HU | 02.08.2012 | |
| AL | 06.10.2021 | ||
| AT | 06.10.2021 | ||
| CY | 06.10.2021 | ||
| CZ | 06.10.2021 | ||
| DK | 06.10.2021 | ||
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| IT | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| MC | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SI | 06.10.2021 | ||
| SK | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2024/18] | HU | 02.08.2012 | |
| AL | 06.10.2021 | ||
| AT | 06.10.2021 | ||
| CZ | 06.10.2021 | ||
| DK | 06.10.2021 | ||
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| IT | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| MC | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SI | 06.10.2021 | ||
| SK | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2023/27] | AL | 06.10.2021 | |
| AT | 06.10.2021 | ||
| CZ | 06.10.2021 | ||
| DK | 06.10.2021 | ||
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| IT | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| MC | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SI | 06.10.2021 | ||
| SK | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2023/16] | AL | 06.10.2021 | |
| AT | 06.10.2021 | ||
| CZ | 06.10.2021 | ||
| DK | 06.10.2021 | ||
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| MC | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SI | 06.10.2021 | ||
| SK | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2023/01] | AL | 06.10.2021 | |
| AT | 06.10.2021 | ||
| CZ | 06.10.2021 | ||
| DK | 06.10.2021 | ||
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SI | 06.10.2021 | ||
| SK | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/49] | AL | 06.10.2021 | |
| AT | 06.10.2021 | ||
| CZ | 06.10.2021 | ||
| DK | 06.10.2021 | ||
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SK | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/35] | AT | 06.10.2021 | |
| CZ | 06.10.2021 | ||
| DK | 06.10.2021 | ||
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SK | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/34] | AT | 06.10.2021 | |
| EE | 06.10.2021 | ||
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RO | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/33] | AT | 06.10.2021 | |
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| SM | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/25] | AT | 06.10.2021 | |
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| NO | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/24] | AT | 06.10.2021 | |
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| NL | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| SE | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| GR | 07.01.2022 | ||
| IS | 06.02.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/23] | AT | 06.10.2021 | |
| ES | 06.10.2021 | ||
| FI | 06.10.2021 | ||
| HR | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| LV | 06.10.2021 | ||
| PL | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| PT | 07.02.2022 | ||
| Former [2022/22] | AT | 06.10.2021 | |
| FI | 06.10.2021 | ||
| LT | 06.10.2021 | ||
| RS | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| Former [2022/21] | AT | 06.10.2021 | |
| RS | 06.10.2021 | ||
| BG | 06.01.2022 | ||
| Former [2022/19] | BG | 06.01.2022 | Documents cited: | Search | [XI] - V. OLIVE ET AL, "miR-19 is a key oncogenic component of mir-17-92", GENES & DEVELOPMENT, (20091215), vol. 23, no. 24, doi:10.1101/gad.1861409, ISSN 0890-9369, pages 2839 - 2849, XP055038529 [X] 3,4,7,8 * the whole document * [I] 5 DOI: http://dx.doi.org/10.1101/gad.1861409 | [A] - A. BAUDRY ET AL, "MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants", SCIENCE, (20100917), vol. 329, no. 5998, doi:10.1126/science.1193692, ISSN 0036-8075, pages 1537 - 1541, XP055045625 [A] 1,2,6-13 * the whole document * DOI: http://dx.doi.org/10.1126/science.1193692 | [T] - N. VOLK ET AL, "MicroRNA-19b Associates with Ago2 in the Amygdala Following Chronic Stress and Regulates the Adrenergic Receptor Beta 1", THE JOURNAL OF NEUROSCIENCE, US, (20141105), vol. 34, no. 45, doi:10.1523/JNEUROSCI.0855-14.2014, ISSN 0270-6474, pages 15070 - 15082, XP055469360 [T] * the whole document * DOI: http://dx.doi.org/10.1523/JNEUROSCI.0855-14.2014 | by applicant | US3687808 | US3791932 | US3839153 | US3850752 | US3850578 | US3853987 | US3867517 | US3879262 | US3901654 | US3935074 | US3984533 | US3996345 | US4034074 | US4036945 | US4098876 | US4331647 | US4469863 | US4476301 | US4666828 | US4683202 | US4801531 | US4879219 | US4946778 | US5011771 | US5023243 | US5034506 | US5166315 | US5177196 | US5185444 | US5188897 | US5192659 | US5214134 | US5216141 | US5235033 | US5264423 | US5264562 | US5264564 | US5272057 | US5276019 | US5278302 | US5281521 | US5286717 | US5321131 | US5399676 | US5405939 | US5405938 | US5434257 | US5453496 | US5455233 | US5466677 | US5470967 | US5476925 | US5489677 | US5519126 | US5536821 | US5539082 | US5541306 | US5541307 | US5545807 | US5545806 | US5550111 | US5561225 | US5563253 | US5569825 | US5571799 | US5587361 | US5596086 | US5602240 | US5608046 | US5610289 | US5618704 | US5623070 | US5625050 | US5625126 | US5633360 | US5633425 | US5661016 | US5663312 | US5677437 | US5677439 | US5714331 | US5719262 | US6303374 | US2004266734 | US2010222413 | - MICHELSEN KA. et al., Brain Res Rev, (20070000), vol. 55, no. 2, pages 329 - 42 | - KRISHNAN V; NESTLER EJ, Nature, (20080000), vol. 455, pages 894 - 902 | - KOSIK KS, Nat Rev Neurosci, (20060000), vol. 7, pages 911 - 20 | - MILLER BH; WAHLESTEDT C, Brain Res, (20100000), vol. 1338, pages 89 - 99 | - MILLAN MJ, Curr Opin Pharmacol, (20110000), vol. 11, no. 1, pages 11 - 22 | - Current Protocols in Molecular Biology, John Wiley & Sons, vol. I-III | - The Concise Encyclopedia Of Polymer Science And Engineering, John Wiley & Sons, (19900000), pages 858 - 859 | - ENGLISCH et al., Angewandte Chemie, (19910000), vol. 30, page 613 | - SANGHVI, Y. S., Antisense Research and Applications, CRC Press, (19930000), pages 289 - 302 | - SANGHVI, Y. S. et al., Antisense Research and Applications, CRC Press, (19930000), pages 276 - 278 | - "GenBank", Database accession no. NR_029485 | - "GenBank", Database accession no. NR_029489.1 | - "GenBank", Database accession no. NR_029500 | - "GenBank", Database accession no. NR_029499 | - "GenBank", Database accession no. NR_029501 | - "GenBank", Database accession no. NR_029677.1 | - "GenBank", Database accession no. NR_029899.1 | - "GenBank", Database accession no. NR_029611.1 | - "GenBank", Database accession no. NR_029614 | - MONKKONEN, J. et al., J. Drug Target, (19940000), vol. 2, pages 299 - 308 | - MONKKONEN, J. et al., Calcif. Tissue Int., (19930000), vol. 53, pages 139 - 145 | - WINTERHALTER M; LASIC D D, Chem Phys Lipids, (19930900), vol. 64, no. 1-3, pages 35 - 43 | - KULKARNI et al., J. Microencapsul., (19950000), vol. 12, no. 3, pages 229 - 46 | - DANENBERG et al., Journal of cardiovascular pharmacology, (20030000), vol. 42, pages 671 - 9 | - Circulation, (20020000), vol. 106, pages 599 - 605 | - Circulation, (20030000), vol. 108, pages 2798 - 804 | - MILLER, A. D., Blood, (19900000), vol. 76, page 271 | - RUSSEL, W. C., J Gen Virol, (20000000), vol. 81, pages 57 - 63 | - "Adenoviral vectors for cancer gene therapy", SETH et al., Adenoviruses: Basic Biology to Gene Therapy, Landes, (19990000), pages 103 - 120 | - PAN et al., Cancer Letts, (20020000), vol. 184, pages 179 - 188 | - ULUDAG, H. et al., "Technology of mammalian cell encapsulation", Adv Drug Deliv Rev, (20000000), vol. 42, doi:doi:10.1016/S0169-409X(00)00053-3, pages 29 - 64, XP002302229 DOI: http://dx.doi.org/10.1016/S0169-409X(00)00053-3 | - LU, M. Z. et al., "Cell encapsulation with alginate and alpha-phenoxycinnamylidene-acetylated poly(allylamine", Biotechnol Bioeng, (20000000), vol. 70, doi:doi:10.1002/1097-0290(20001205)70:5<479::AID-BIT1>3.0.CO;2-E, pages 479 - 483, XP008025769 DOI: http://dx.doi.org/10.1002/1097-0290(20001205)70:5<479::AID-BIT1>3.0.CO;2-E | - CHANG, T. M.; PRAKASH, S., "Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms", Mol Biotechnol, (20010000), vol. 17, pages 249 - 260 | - LU, M. Z. et al., "A novel cell encapsulation method using photosensitive poly(allylamine alpha-cyanocinnamylideneacetate", J Microencapsul, (20000000), vol. 17, pages 245 - 521 | - CHIA, S. M. et al., "Multi-layered microcapsules for cell encapsulation", Biomaterials, (20020000), vol. 23, doi:doi:10.1016/S0142-9612(01)00191-0, pages 849 - 856, XP004322709 DOI: http://dx.doi.org/10.1016/S0142-9612(01)00191-0 | - SAMBANIS, A., "Encapsulated islets in diabetes treatment", Diabetes Thechnol Ther, (20030000), vol. 5, pages 665 - 668 | - CANAPLE, L. et al., "Improving cell encapsulation through size control", J Biomater Sci Polym Ed, (20020000), vol. 13, pages 783 - 96 | - WILLIAMS, D., "Small is beautiful: microparticle and nanoparticle technology in medical devices", Med Device Technol, (19990000), vol. 10, pages 6 - 9 | - DESAI, T. A., "Microfabrication technology for pancreatic cell encapsulation", Expert Opin Biol Ther, (20020000), vol. 2, pages 633 - 646 | - Remington's Pharmaceutical Sciences, Mack Publishing Co. | - FINGL et al., The Pharmacological Basis of Therapeutics, (19750000), page l | - NUOVO GJ et al., "Intracellular localization of polymerase chain reaction (PCR)-amplified hepatitis C cDNA", Am J Surg Pathol., (19930000), vol. 17, pages 683 - 90 | - KOMMINOTH P et al., "Evaluation of methods for hepatitis C virus detection in archival liver biopsies. Comparison of histology, immunohistochemistry, in situ hybridization, reverse transcriptase polymerase chain reaction (RT-PCR) and in situ RT-PCR", Pathol Res Pract., (19940000), vol. 190, pages 1017 - 25 | - PORTER, R. R., Biochem. J., (19590000), vol. 73, pages 119 - 126 | - INBAR et al., Proc. Nat'l Acad. Sci. USA, vol. 69, pages 2659 - 62 | - WHITLOW; FILPULA, Methods, (19910000), vol. 2, pages 97 - 105 | - BIRD et al., Science, (19880000), vol. 242, pages 423 - 426 | - PACK et al., Bio/Technology, (19930000), vol. 11, pages 1271 - 77 | - LARRICK; FRY, Methods, (19910000), vol. 2, pages 106 - 10 | - HOOGENBOOM; WINTER, J. Mol. Biol., (19910000), vol. 227, page 381 | - MARKS et al., J. Mol. Biol., (19910000), vol. 222, page 581 | - COLE et al., Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, (19850000), page 77 | - BOERNER et al., J. Immunol., (19910000), vol. 147, no. 1, pages 86 - 95 | - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783 | - LONBERG et al., Nature, (19940000), vol. 368, pages 856 - 859 | - MORRISON, Nature, (19940000), vol. 368, pages 812 - 13 | - FISHWILD et al., Nature Biotechnology, (19960000), vol. 14, pages 845 - 51 | - NEUBERGER, Nature Biotechnology, (19960000), vol. 14, page 826 | - LONBERG; HUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93 | - AVIVI C. et al., J Histochem. Cytochem. 1994, (19940000), vol. 42, pages 551 - 4 | - Current Protocols in Molecular Biology, (19940000), vol. I-III | - WATSON et al., Recombinant DNA, Scientific American Books | - Genome Analysis: A Laboratory Manual Series, Cold Spring Harbor Laboratory Press, (19980000), vol. 1-4 | - Cell Biology: A Laboratory Handbook, (19940000), vol. I-III | - Current Protocols in Immunology, (19940000), vol. I-III | - Methods in Enzymology, Academic Press, vol. 1-317 | - CHEN A. et al., Mol Endocrinol, (20050000), vol. 19, pages 441 - 58 | - KRISHNAN V. et al., Cell, (20070000), vol. 131, pages 391 - 404 | - NALDINI L et al., Proc Natl Acad Sci USA, (19960000), vol. 93, pages 11382 - 8 | - SINGER O. et al., Nat Neurosci, (20050000), vol. 8, pages 1343 - 9 | - CHEN A et al., J Neurosci, (20060000), vol. 26, pages 5500 - 10 | - FU A et al., Brain Res, (20080000), vol. 1211, pages 85 - 92 | - RUDOY CA; VAN BOCKSTAELE EJ, Prog Neuropsychopharmacol Biol Psychiatry, (20070000), vol. 31, pages 1119 - 29 | - ROOZENDAAL B et al., J Neurosci, (20040000), vol. 24, pages 8161 - 9 | - ROOZENDAAL B et al., Neuroscience, (20060000), vol. 138, pages 901 - 10 | - WANG H et al., Nat Neurosci, (20040000), vol. 7, pages 635 - 42 | - VENTURA A et al., Cell, (20080000), vol. 875-86, no. 5, page 132,7 | - DRAGATSIS I et al., Genesis, (20000000), vol. 26, no. 2, pages 133 - 5 | - HERKENHAM M. et al., The Journal of neuroscience: the official journal of the Society for Neuroscience, (19910000), vol. 11, pages 563 - 583 | - MACKIE, K., Handbook of experimental pharmacology, (20050000), pages 299 - 325 | - ROOZENDAAL, B. et al., Neurobiology of learning and memory, (20060000), vol. 86, pages 249 - 255 | - HILL M.N.; MCEWEN B.S., Proc of the Nat Acad of Sci of the USA, (20090000), vol. 106, pages 4579 - 4580 | - MEISTER G. et al., Molecular cell, (20040000), vol. 15, pages 185 - 197 | - BINDER, E.B. et al., Nature genetics, (20040000), vol. 36, pages 1319 - 1325 | - YEHUDA, R. et al., Biological psychiatry, (20090000), vol. 66, pages 708 - 711 | - SABA. R. et al., Molecular and Cellular Biology, (20120000), vol. 32, no. 3, pages 619 - 32 | - SAUS E et al., Hum Mol Genet., (20100000), vol. 19, no. 20, pages 4017 - 25 | - SMALHEISER NR et al., Int J Neuropsychopharmacol., (20110000), pages 1 - 11 |